| |
Baseline
|
HS
|
LS
| |
|---|
|
Post
|
Δ High
|
Post
|
Δ Low
|
Δ High x Δ Low
|
|---|
|
Median
|
IQR
|
Median
|
IQR
|
Median
|
IQR
|
Median
|
IQR
|
Median
|
IQR
|
p
|
|---|
|
Urinary SA
|
2.62
|
4.5
|
0.92
|
0.8
|
−1.7
|
3.0
|
0.6
|
3.4
|
−1.13
|
2.1
|
0.338
|
|
Urinary SU
|
37.9
|
45.6
|
23.82
|
54.3
|
−16.76
|
31.6
|
44.21
|
34.6
|
−7.35
|
19.3
|
0.482
|
|
Urinary CysLT
|
819.88
|
2649.6
|
771.99
|
1327.9
|
− 173.17
|
1065.2
|
874.05
|
1221.4
|
− 184.58
|
1518.9
|
0.949
|
|
Urinary Cr
|
10.3
|
11.3
|
*15.3
|
12.6
|
2.6
|
8.4
|
9.9
|
11.3
|
−0.3
|
11.1
|
0.655
|
|
SNOT - 22
|
66
|
40
|
64
|
40
|
7
|
15
|
*44
|
31
|
−10
|
24
|
0.013
|
- HS High-Salicylate Diet, LS Low-Salicylate Diet, SA Salicylic Acid (ng/ml), SU Salicyluric Acid (ng/ml), CysLT Cysteinyl leukotrienes (pg/ml), Cr Creatine (mmol/L), SNOT − 22 Sino-nasal outcome test, Δ High Post - Baseline of High-Salicylate diet group, Δ Low Post - Baseline of Low-salicylate diet group. * significance p ≤ 0.05 (Wilcoxon Test; baseline x post); Δ High x Δ Low = intergroup dietary effect comparison (Mann Whitney U test)
